InterCure To Acquire Israel-Based Medical Cannabis Producer Better For $35M
InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR), which is doing business as Canndoc, has signed a definitive agreement to acquire Cann Pharma...
Stay updated with breaking news from Intercure Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR), which is doing business as Canndoc, has signed a definitive agreement to acquire Cann Pharma...
Estimated revenue reaches over CAD$31 million Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue throughout 2022 TORONTO and... | February 8, 2022
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue – 3 Times YoY and 24% QoQ Growth. Estimated revenue reaches over CAD$31 million (a record NIS 77 million)... #Canndoc #INCR #INCRU
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Cookies Partners With Leading Global Cannabis Company InterCure to Open Retail Locations in Austria and the U.K. in Early 2022 Iconic cannabis brand Cookies today announced its international expansion